Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Preliminary phase IIb results display encouraging responses to Celldex' CDX-011

May 24, 2012

Korean scientists present novel HIF-1 inhibitors

May 24, 2012

Seattle Genetics' Adcetris NDS accepted for review by Health Canada

May 24, 2012

Novel pegylated interferon alpha variant conjugates generated in China

May 24, 2012

AVEO begins phase I AV-203 study in advanced solid tumors

May 24, 2012

Combination of Ad-rhE and chemotherapy proves beneficial in cancer patients

May 24, 2012

Oncolytic viral therapy shows potential as treatment for superficial tumors

May 24, 2012

Novel antimitotic compounds created in joint venture

May 24, 2012

Adva-27a shows superior pharmacokinetic profile than etoposide

May 23, 2012

Phase III HA-irinotecan study to continue enrollment

May 23, 2012

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 8, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
Hantavirus is ‘sentinel’ more than acute pandemic threat
BioWorld
News of eight infections and three deaths so far due to an emerging zoonotic virus has brought back unhappy memories of the early days of SARS-CoV-2. At a press...
Cytospire raises £61M series A to target EGFR in solid tumors
BioWorld
Next-generation T-cell engager (TCE) specialist Cytospire Therapeutics Ltd. has raised £61 million (US$82.7 million) in a series A round, equipping it to advance...